Table 2.
Unrelated Donor |
Autologous |
|||||
---|---|---|---|---|---|---|
All patients (n = 159) |
CR1 (n = 76) |
CR2 (n = 83) |
All patients (n = 101) |
CR1 (n = 64) |
CR2 (n = 37) |
|
TRM | ||||||
@ 100 days | 28% | 23% | 32% | 5% | 5% | 6% |
@ 1 year | 43% | 45% | 41% | 8% | 9% | 6% |
@ 2 years | 45% | 47% | 43% | 9% | 12% | |
Relapse | ||||||
@ 1 year | 13% | 5% | 21% | 49% | 38% | 69% |
@ 2 years | 18% | 12% | 23% | 54% | 41% | 75% |
@ 3 years | 20% | 15% | 25% | 58% | 45% | 81% |
@ 5 years | 21% | 15% | 26% | 58% | 45% | 81% |
Leukemia-Free Survival | ||||||
@ 1 year | 43% | 49% | 38% | 42% | 52% | 24% |
@ 2 years | 37% | 41% | 33% | 37% | 47% | 19% |
@ 3 years | 35% | 39% | 31% | 31% | 42% | 14% |
@ 5 years | 33% | 37% | 29% | 29% | 39% | 14% |
Overall Survival | ||||||
@ 1 year | 47% | 51% | 42% | 52% | 59% | 41% |
@ 2 years | 40% | 45% | 36% | 41% | 51% | 24% |
@ 3 years | 37% | 42% | 33% | 37% | 48% | 19% |
@ 5 years | 34% | 38% | 30% | 29% | 39% | 14% |
Legend: CR1 = first complete remission; CR2 = second complete remission; TRM = Treatment-related mortality.